A B S T R A C T We have histocompatibility (HLA) genotyped 24 families with two or more juvenile, insulin-dependent, ketosis-prone diabetic siblings. This criterion for family selection was used to obtain a homogeneous form of diabetes within a sibship, because diabetes appears to be a genetically heterogeneous disease. 58 diabetic and 53 nondiabetic sibs and 40 parents were studied. 55% of the diabetic pairs were concordant for both HLA haplotypes (expected 25%), 40% were concordant for one haplotype (expected 50%), and 5% were discordant for both haplotypes (expected 25%). These values are significantly different from the expected values (P < 0.001). On the other hand, the inheritance of haplotypes among the nondiabetic sibs in these families was not significantly different from the expected mendelian segregation.
INTRODUCTION
Recent studies ofjuvenile, insulin-dependent diabetes mellitus (JIDD)l have pointed out the importance of hereditary factors in this disease. Uncertainty remainis about the mode of inheritance, howvever, and all kniown genetic mechanisms have been suggested (1) . Evidence from diabetic twin studies has hinited at important environmental factors in the pathogeniesis of at least some cases of JIDD (2) , and findings of associations betwteen histocompatibilitv (HLA) antigens and JIDD have strengthened the genetic theory of the disease. Associations of HLA anitigens B8 (3) (4) (5) , BW15 (3, (4) (5) (6) , CW3 (7) , and DW3 (8) have been described with JIDD, and it has been postulated that a gene (or genes) linked to and in disequilibrium with loci B and D of the HLA complex is important in the pathogenesis of this form of diabetes (4) . Similar findings have not been found with typical adultonset, insulin-independent diabetes, confirming the belief that these two forms of diabetes are genetically different. Maturity-onset type of diabetes in the young, another form of insulin-independent diabetes, may be associated with HLA antigens (9) , although opposing evidence has been reported (10) . 
989
HLA studies have not only confirmed the previously known clinical and biochemical evidence (1) that diabetes mellitus is a genetically heterogeneous disease, but have also suggested that JIDD itself is heterogeneous. In fact, population studies have shown that subjects with B8 and BW15 B-locus genotype have (a) higher relative risk for the development of JIDD (11, 12) , (b) earlier onset of disease (12) , and (c) lower plasma concentrations of C-peptide (12) , a presumed indication of more severe 38-cell damage, than subjects carrying either B8 or BW15. An association between the presence of BW15 and higher insulin antibody titers (12, 13) , a possible indicator of more severe JIDD (12, 14) , has also been reported.
The identification of a patient sample likely to harbor genetically homogeneous JIDD would be of interest. The study of individual families with higher intrasibship prevalence of diabetes may be informative because genetic homogeneity of the disease is more likely in the affected sibs. Because of the previous work suggesting an association of HLA and diabetes, studies of HLA antigens in such families may allow a better understanding of the genetic mechanisms involved. HLA antigens are determined by alleles at four closely linked loci (A, B, C, and D). The set of alleles at the four loci on a single chromosome determines the haplotype, and an individual inherits two haplotypes, one from each parent. Susceptibility to diabetes associated with HLA antigens may result in concordance between HLA and diabetes. Because HLA haplotypes differ among families, an association between a specific haplotype and diabetes may be more easily detectable by studying families with many affected individuals.
In a recent study of HLA haplotypes in 17 families with several cases of JIDD per sibship, the frequency of HLA haploidentity (sharing of one or two HLA haplotypes) between the diabetic siblings within each sibship was found to be about 90%, as opposed to the expected 75% (4) . Another study of 10 kindreds with JIDD did not confirm these findings (15) . The HLA haplotypes of the parents were not given in the first of these studies, and the haplotypes of the healthy siblings were not available in either report. Furthermore, control, nondiabetic families were not included in these reports. Inasmuch as the study of the nonaffected siblings affords the best control population in family analysis of disease, we have studied the HLA haplotypes (A and B loci) in 24 nearly complete sibships with two or more cases of JIDD and the parents. 92 nondiabetic families served as controls. All diabetics were insulin-dependent and ketosis-prone, with the onset of the disease at 11±8 yr of age. The onset of diabetes was before the age of 40 in all patients. All families filled out a questionnaire for each diabetic that included the following information: the age and month of onset of diabetes, history of infections during 3 mo before the onset of the disease, ethnic background, family history of diabetes, and personal and family history of other diseases. The onset of polydipsia or polyuria, as usually recorded in "baby books" or remembered by the mother, was considered the onset of the disease. This was usually 4-8 wk before the diagnosis was established in the first diabetic of the family, but less than 2 wk for the other diabetics in the family.
METHODS
Immunogenetic studies. 29 HLA antigens were determined with a standard two-stage dye exclusion microcytotoxicity test (16) by using a panel of 90 well-characterized antisera capable of detecting all defined HLA and most "W" specificities. HLA antigens were assigned without knowledge of disease. In the eight families in which the fathers were not available, one or both paternal haplotypes were deduced from those found in the rest of the family.
92 families tissue typed for bone marrow and kidney transplant or for HLA studies unrelated to diabetes or to antigens that have been associated with diabetes (Al, A2, B8, B18, BW15, BW40) were used to determine the normal haplotype frequency in the Caucasian population in Minnesota. The parents of these nondiabetic families were used as controls. 343 typed haplotypes were counted in these control families.
Significance of associations was tested by chi-square analysis and t tests for unpaired data. Table I show, respectively, the pedigrees of the 24 kindreds studied, and the haplotypes in each family. 92 haplotypes were determined directly (87%), 12 haplotypes were deduced, and 4 could not be determined, all of the latter in fathers. There were four haplotypes with one antigen blank (7%), and there were four homozygotes for locus A, and five for locus B. Tables II and III show the HLA haplotype concordance rates for diabetic-diabetic, diabetic-healthy, and healthy-healthy sib pairs in the 24 families. 55% of the diabetic pairs were concordant for both HLA haplotypes (expected 25%), 40% were concordant for one haplotype (expected 50%), and 5% were discordant for both haplotypes (expected 25%). These values are D.D. M.R.
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A.S. significantly different from the expected values for all distributions of parental haplotypes (P < 0.001). The haplotype assortment followed mendelian segregation for the nondiabetic siblings. Table IV shows the HLA haplotype concordance rate for our kindreds pooled with the 17 diabetic multiplex families reported from Great Britain (4) . The pooled data is similar to that shown in Tables II  and III , and the observed values are significantly different from those expected (P < 0.001). 10 additional reported diabetic families (15) are not included here because a claimed high frequency of intra-HLA recombination ratio has not been confirmed by us.
However, our results would not be significantly changed by the addition of these families. Table V shows the frequencies of haplotypes A1,B8, Al,BW15, A2,BW15, A2,BW40, and A2,B8 in 92 control and 24 diabetic multiplex families. These specific haplotypes were studied because they showed a trend for increased frequency in the diabetic kindreds. There were appreciable increases in the frequency of haplotypes Al,BW15, A2,BW15, A2,BW40, and A2,B8, but the numbers were too small for statistical analysis. Haplotype A1,B8 was not more frequent in the diabetic families, in spite of the recognized association of JIDD with B8 (3) (4) (5) and in some reports with Al (5) . Fig. 1 The frequencies of the various HLA A and B antigens in unrelated controls, diabetic sibs, and healthy sibs in the 24 diabetic multiplex kindreds are shown in Table VI . Al, AW24, B8, and BW15 showed an upward trend, and B5, B12, B13, and B14 showed a could not be assigned to the deceased downward trend in the diabetic sibs. In the healthy sibs, upward trends were seen for antigens Al, A2, A3, B8, and BW15, and downward trends for B5, B12, and B13. Table III ). 992 Barbosa, King, Noreen, and Yunis Table VIII shows that the HLA identical diabetic sibs (concordant for two haplotypes) were significantly more concordant for the difference in age of onset of disease in years (3.9 vs 7.3 yr; P < 0.05) and difference in seasonal incidence in months (1.8 vs 3.2 mo; P < 0.025) than the haplo-identical diabetic sibs (concordant for one haplotype). In the only family (M. R.) with one diabetic sib discordant for both haplotypes, the difference in age of onset of disease between the two diabetic HLA identical sibs, on the one hand (age of onset 1 yr), and the discordant diabetic sib, on the other hand (age of onset 13 yr), was most striking. This type of analysis did not elicit significant differences for family history of disease, frequency of vascular concomitants, or sex of patients. Fig. 2 depicts the distribution of HLA identical and HLA haploidentical diabetic sibs according to the month in which the disease had started. The families L. D., H. P., and D. S. were excluded from this analysis because they included both HLA identical and haploidentical diabetic sibs. The HLA identical diabetics had the onset of diabetes more frequently in the winter months of November through April (78%) than the haploidentical diabetic sibs (21%). Includes deduced haplotypes (see Table I ). Against a two-gene model is the fact that diabetic siblings that were HLA identical and diabetic siblings that were only one-haplotype identical were found within the same sibship. It seems unlikely that two separate diabetes response genes would be segregating in the same family.
Another possibility is that there is one diabetes response gene segregating in these f:amilies and that it is expressed codominantly with the normal allele from this locus. For those individuals with a single copy of this abnormal gene, the environmental stimuli must be great to produce diabetes and a number of individuals carrying this gene will escape its development. When an individual is homozygous for this diabetes response gene, it is more likely that diabetes will develop. A variation of this mechanism would be that there are a number of diabetic alleles at the diab)etes response locus, and an affected individual could be heterozygous and carry two separate diabetic alleles. Multiple allelism has been suggested as one explanation of genetic heterogeneity (18) . For both situations, the clinical expression for the diabetes is the same after onset of the disease. The data from the families reported here fit this explanation best. Higher concordance for age of onset and seasonal incidence of the disease in the HLA identical, as compared with the haploidentical diabetic sibs, is compatible with this interpretation. There are many nondiabetic siblings that share one haplotype but few that share both. Evidence against this genetic mechanism is the fact that none of the parents in these 24 families is diabetic; however, it is possible that the parents escaped diabetes because of the lack of an appropriate environmental stimulus, whereas a strong stimulus occurred with the diabetic offspring. The same stimulus may no longer affect the parents at the time the offspring are affected. An (19) and hyperglycemia in certain strains of mice (20, 21) are thought to be virus induced. There is a marked variation in the incidence of JIDD in families with both parents diabetic (22) . Abnormal humoral and cell-mediated immune function has been found in some but not all JIDD patients studied (23) . The concordance rate for JIDD in identical twins is only about 50% (2) .
Epidemiologic studies in Great Britain (24) and the United States (25) have shown that JIDD starts somewhat more frequently in the winter and fall. Data from the register of newly diagnosed diabetic children in Great Britain (26) , including more than 2,000 cases, have confirmed a seasonal variation in incidence in children 5-15 yr of age with peaks in the fall and winter. No seasonal variation in incidence was seen in children age 0-4 yr at onset of diabetes. Epidemiologic studies searching for relationships between HLA antigens and month of onset of diabetes have given conflicting results (27, 28) . In addition, evidence of geographical variations in incidence from year to year, and the occurrence of diabetes almost simultaneously in sibs of different ages within the same kindred were noted (26 Mononuclear cell infiltration of islets in early JIDD (23) and in experimental viral diabetes (29) , cell-mediated immunity abnormalities in about 30% of the JIDD patients studied (23) , and islet cell antibodies in 80% of B8-positive JIDD patients early in the course of the disease (30) , all suggest an underlying immune abnormality.
An immune response gene that controls T-cell function may be important in diabetes, as shown by the fact that athymic mice from strains that are normally susceptible to viral diabetes develop neither mononuclear cell infiltration nor hyperglycemia after an adequate viral challenge, although the viruses do colonize their islets (29) .
If the diabetes response gene controls immune response, then it appear to be closely associated with the HLA system. JIDD in diabetic populations has been associated with HLA B8 (3) (4) (5) and BW15 (3, 4, 6) , and the relative risk for diabetes in a subject carrying both antigens has been said to be 10-fold that of individuals without those antigens (11) . As shown in Table  V , antigens B8 and BW15 showed an upward trend as reported earlier (3) (4) (5) . Some ofthe haplotypes shown in Table V seemed increased in diabetic families, but the numbers were two small for statistical analysis. Many other haplotypes were associated with JIDD in these families, however, and it seems unlikely that any specific HLA antigen plays a direct role in the development of diabetes.
It is possible that the JIDD present in our families is not representative of all or even most cases of JIDD, 2 Balfour, H. Personal communication.
which are often seen as isolated cases in their respective families.
It has been claimed in preliminary reports on both population (31) and family (32) studies that the frequency of HLA antigen B7 is significantly decreased among JIDD patients. However, the family study (32) that did not specify whether all the previously known diabetics were insulin-dependent, apparently included in the analysis relatives of the diabetics with abnormal 2-h postprandial glucose tolerance but not overt diabetes. These data have been interpreted as suggesting that B7 is associated with a genetic protective factor for diabetes. Our family data show no disturbance of B7 frequency in the diabetic sibs, although other B alleles, especially B5, B 12, B 13, and B 14, showed a downward trend. It is possible that this simply reflects the higher frequency of alleles B8 and BW15 in this population.
An intra-HLA recombination rate of 16% (both A/B and B/D) has been reported in both diabetic and nondiabetic sibs in a study of 10 diabetic families that included a total of 37 siblings (15) . This frequency of recombination is at least 100-fold higher than that expected, and our data do not support these findings. In the 42 kindreds reported here and elsewhere (4), including at least 187 siblings, only one definitive A/B HLA crossover in Cudworth and Woodrow's kindreds (4) was observed, resulting in a recombination frequency of < 1%.
In conclusion, our HLA studies of diabetic multiplex families confirm the marked genetic heterogeneity of JIDD, seen even among diabetic sibs. Although the data described here are compatible with the existence of one or more diabetes response genes associated with the HLA, it is possible that in some of the families studied the association of diabetes with HLA is fortuitous.
